MTOR and acute myeloid leukemia: Finally, sorafenib-resistant FLT3-ITD-positive cell lines and blood samples from AML patients showed aberrant expression of signaling molecules of the PI3K/mTOR pathway, which has been linked to the development of drug resistance [86,87].